Author:
Chukwuka Nnamdi H.,Hashmi Arsalan T.,Kamholz Stephan L.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference18 articles.
1. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study;Tefferi;J Clin Oncol.,2011
2. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995;Mesa;Am J Hematol.,1999
3. Primary myelofibrosis: update on definition, pathogenesis, and treatment;Abdel-Wahab;Annu Rev Med.,2009
4. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs);Mesa;Cancer.,2007
5. Long-term outcome of treatment with ruxolitinib in myelofibrosis;Tefferi;N Engl J Med.,2011
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献